More than a dozen CUIMC employees shared their reasons for COVID-19 vaccination as part of the Roll Up Your Sleeves NY COVID-19 public education campaign.
A trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%).
A virtual town hall hosted by CUIMC and NewYork-Presbyterian brought together community health workers and local leaders for a discussion of post-COVID syndrome or “long COVID.”
Columbia cancer researchers are testing a new chemotherapy regimen for patients with an invasive form of bladder cancer who have limited options beyond radical surgery if initial treatment fails.
Newly identified immune cells infiltrate tumors in patients with localized kidney cancer and may be driving the cancer’s recurrence, Columbia researchers have found.
